Skip to main content

Emma

Analyst

Piper Sandler

Equibles does not estimate personal net worth.

About Emma

Emma is recorded as Analyst at Piper Sandler. Emma has spoken on 2 earnings calls across 2 companies, most recently for Madrigal Pharmaceuticals, Inc. on February 19, 2026. Those appearances were for Madrigal Pharmaceuticals, Inc. (MDGL) and Prothena Corp Public Ltd Co (PRTA). The companies whose calls Emma spoke on are classified in the Healthcare sector.

Emma on recent calls

“Firstly, maybe help us understand for Maestro Nash outcomes in F4C, how are you tracking blinded event rates, and how is this, like, tracking for on-time data? At what point in this year might you tighten guidance in that regard?”
Analyst — Piper Sandler, Madrigal Pharmaceuticals, Inc. Q4 FY2025 Earnings Call ·
“Firstly, what is considered the best, the base and best case scenario into the phase three Affirm AL, both on the primary endpoint as well as key secondaries?”
Analyst — Piper Sandler, Prothena Corp Public Ltd Co Q4 FY2024 Earnings Call ·

Affiliation history

  • Piper Sandler

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity